Hurotics raises KRW 25 billion to expand rehabilitation and walking-assistance robots

Hurotics has raised KRW 25 billion in Series A funding led by Atinum Investment, bringing cumulative funding above KRW 33.5 billion. Returning investors included Stonebridge Ventures and Industrial Bank of Korea, while Mirae Asset Venture Investment and strategic investors Daewoong, Naver and Lotte joined the round. The company will fund overseas regulatory approvals and distribution for H-Medi, its medical walking-rehabilitation exosuit, alongside development and mass production of H-Care, a walking-assistance robot for everyday use.

The investment backs a specific physical-AI application: wearable systems that analyze gait through sensors and provide supplemental assistance. H-Medi launched commercially in September 2025, entered major South Korean hospitals including Severance Hospital, and was exported to the University of Illinois Chicago in June 2026. Those deployments place Hurotics at the intersection of task-specific robotics and clinical procurement, where regulatory access and use in care settings matter alongside technical capability. Its longer-term plan to predict muscle loss and fall risk would extend the business from physical assistance into software, but the report provides no validation results for those predictions.

For investors, the concrete diligence question is whether Hurotics can turn hospital deployments into repeatable sales while financing a separate everyday-use product. Overseas approvals, H-Care manufacturing progress and repeat purchases offer clearer milestones than the planned physical-AI data platform alone. The round funds that expansion; it does not establish the economics of either product line.